Goebel Nora, Bonte Daniel, Salehi-Gilani Schahriar, Nagib Ragi, Ursulescu Adrian, Franke Ulrich F W
From the Department of Cardiac and Vascular Surgery, Robert-Bosch-Hospital, Stuttgart, Germany.
Innovations (Phila). 2017 Sep/Oct;12(5):351-355. doi: 10.1097/IMI.0000000000000390.
Median sternotomy is still the standard approach for aortic arch surgery. Minimally invasive techniques promise faster recovery with shorter hospital stay due to thoracic stability, reduced pain, and superior cosmetic results. However, safety is a concern in complex aortic surgery. The aim of our study was to demonstrate that aortic arch surgery via partial upper sternotomy is viable, safe, and equivalent to standard procedure both in terms of its safety and the risk of major adverse cardiac and cerebrovascular events.
We interrogated our prospectively collected database and identified a total of 21 nonemergent patients operated on at our center between October 2008 and February 2015. Indication for operation was aneurysmatic disease in 18 and aortic dissection in 3 patients. Data were analyzed for in-hospital mortality, stroke, bleeding complications, and acute kidney injury.
Mean ± standard deviation age of patients was 69.3 ± 14.4 years, 57.1% were female, and mean ± standard deviation logistic EuroSCORE was 17.0 ± 7.2%. Surgery on the aortic arch comprised proximal arch in 9, hemiarch in 9, and total arch replacement plus frozen elephant trunk in 3 patients. Concomitant procedures included aortic root repair in 10, aortic root replacement in 2, and aortic valve replacement in 3 patients. We lost one patient because of septic shock, no stroke occurred, but a transient neurologic deficit in three and a postoperative delirium in four patients. Re-exploration for bleeding was necessary in two patients, and one patient had acute kidney injury.
Minimally invasive aortic arch surgery via partial upper sternotomy does not increase the risk of morbidity or mortality. Thus, in experienced hands, it is viable, safe, and therefore favorable and as a result should be offered to more patients.
正中胸骨切开术仍是主动脉弓手术的标准术式。微创技术有望因胸廓稳定性、疼痛减轻及美容效果更佳而实现更快康复和缩短住院时间。然而,复杂主动脉手术中的安全性仍是一个问题。我们研究的目的是证明经部分上胸骨切开术进行主动脉弓手术是可行、安全的,并且在安全性以及主要不良心脑血管事件风险方面与标准手术相当。
我们查阅了前瞻性收集的数据库,确定了2008年10月至2015年2月期间在我们中心接受手术的21例非急诊患者。手术指征为18例动脉瘤性疾病和3例主动脉夹层。分析了住院死亡率、中风、出血并发症和急性肾损伤的数据。
患者的平均年龄±标准差为69.3±14.4岁,57.1%为女性,平均逻辑欧洲心脏手术风险评估系统(EuroSCORE)±标准差为17.0±7.2%。主动脉弓手术包括9例近端弓手术、9例半弓手术和3例全弓置换加象鼻支架植入术。同期手术包括10例主动脉根部修复、2例主动脉根部置换和3例主动脉瓣置换。我们有1例患者因感染性休克死亡,未发生中风,但3例出现短暂性神经功能缺损,4例出现术后谵妄状态。两名患者因出血需要再次手术探查,1例患者发生急性肾损伤。
经部分上胸骨切开术的微创主动脉弓手术不会增加发病或死亡风险。因此,在经验丰富的医生手中,它是可行、安全的,因此是有利的,应提供给更多患者。